Metabolic effects of kiwifruit in people with prediabetes

Not Applicable

Completed

• Conditions: Diabetes; prediabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12618000329268
• Lead Sponsor: ew Zealand Institute for Plant and Food Research Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-06
• Study Completion: 2018-12-14
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

All participants have pre-diabetes and may or may not be taking medication

Exclusion Criteria

Intolerance of kiwifruit.
Allergic to kiwifruit
Planned change in diet or medication within the trial period
Any illness or gastrointestinal disorder within the 3 weeks prior to the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in HbA1c level<br>Change in HbA1c level in the blood sample. HbA1c between 41-49 mmol/mol is considered as prediabetic range. Therefore, change in HbA1c value would be monitered[Blood samples will be taken at the start of the trial and at the end of twelve weeks]

Secondary Outcome Measures

Name	Time	Method
Plasma lipid profile: HDL cholesterol, LDL cholesterol and total lipids.<br>[Blood samples will be taken at the start of the trial and at the end of twelve weeks.];Insulin[Blood samples will be taken at the start of the trial and at the end of twelve weeks.];Uric acid[Blood samples will be taken at the start of the trial and at the end of twelve weeks.];creatinine[Blood samples will be taken at the start of the trial and at the end of twelve weeks.];biomarkers of inflammation eg, c-reactive proteins[Blood samples will be taken at the start of the trial and at the end of twelve weeks.]